• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·HL.BK
Share

Healthlead Public Company Limited Stocks

THB 4.48Last Updated 03.11.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

THB 33.55M

THB 4.48
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Healthlead Public Company Limited, along with its subsidiaries, specializes in the creation, sourcing, and distribution of a wide array of health-related goods. This portfolio encompasses pharmaceuticals, medicinal preparations, beauty aids, nutritional supplements, and medical devices. Their offerings also include hygiene products like disinfectants and deodorizers, notably masks, sold under brand names such as iCare, Pharmax, vitaminclub, and Super Drug. Furthermore, nutritional supplements are marketed under the PRIME and Besuto brands. Diversifying its operations, the company engages in property leasing, event planning, restaurant management, and operates its own medical clinic. It maintains a retail footprint through 28 pharmacy locations: 11 iCare, 13 Pharmax, 3 vitaminclub, and 1 Super Drug. The company was founded in 2018 and has its principal office in Nonthaburi, Thailand.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, reasonably

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

05.11.2026 02:14

The Dow soared 3% following the Democrats' election victory: this is its best gain in 1.5 years

05.11.2026 01:29

Five tech giants gain $750 bln post-midterms. JPMorgan sees the rally broadening.

05.11.2026 00:54

Shares of defense companies fell following the Democrats' success in the U.S. What happens next?

05.11.2026 00:02

Brent crude falls 10% as Democratic sweep raises hopes for end to Iran war

04.11.2026 23:06

"In the Spotlight": Why Tesla and SpaceX Stocks Are Falling Despite the Market's Uptrend

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026